Chapter

3. A Shorter Hospital Stay for Imdelltra

From 10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE by 10 Cancer Treatment Approvals From September 2026 and What They Mean for You

Concepts

1. Monitoring Update

   "People starting Imdelltra (tarlatamab) for extensive-stage small cell lung cancer now need 6 to 8 hours of monitoring after each of their first two doses, down from 22 to 24 hours. Patients must stil

2. Patient Access

   "What it means for you: Less time in the hospital could make Imdelltra easier to start, especially for people who live far from a cancer center. When the drug was first approved in 2024, Dr. Roy Herbs